PCI Biotech Holding ASA PCIB.OL Stock
PCI Biotech Holding ASA Price Chart
PCI Biotech Holding ASA PCIB.OL Financial and Trading Overview
| PCI Biotech Holding ASA stock price | 1.78 NOK |
| Previous Close | 2.48 NOK |
| Open | 2.48 NOK |
| Bid | 2.35 NOK x 20000 |
| Ask | 2.38 NOK x 12500 |
| Day's Range | 2.3 - 2.62 NOK |
| 52 Week Range | 1.52 - 5.96 NOK |
| Volume | 186.4K NOK |
| Avg. Volume | 105.35K NOK |
| Market Cap | 100.94M NOK |
| Beta (5Y Monthly) | 1.907279 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.79 NOK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PCIB.OL Valuation Measures
| Enterprise Value | 55M NOK |
| Trailing P/E | N/A |
| Forward P/E | -0.7996575 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 26.605768 |
| Price/Book (mrq) | 1.6714389 |
| Enterprise Value/Revenue | 14.496 |
| Enterprise Value/EBITDA | -1.2 |
Trading Information
PCI Biotech Holding ASA Stock Price History
| Beta (5Y Monthly) | 1.907279 |
| 52-Week Change | -45.85% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.96 NOK |
| 52 Week Low | 1.52 NOK |
| 50-Day Moving Average | 1.96 NOK |
| 200-Day Moving Average | 2.09 NOK |
PCIB.OL Share Statistics
| Avg. Volume (3 month) | 105.35K NOK |
| Avg. Daily Volume (10-Days) | 326.27K NOK |
| Shares Outstanding | 37.33M |
| Float | 29.57M |
| Short Ratio | N/A |
| % Held by Insiders | 31.97% |
| % Held by Institutions | 6.80% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1054.95% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.95% |
| Return on Equity (ttm) | -53.97% |
Income Statement
| Revenue (ttm) | 3.79M NOK |
| Revenue Per Share (ttm) | 0.1 NOK |
| Quarterly Revenue Growth (yoy) | -80.50% |
| Gross Profit (ttm) | 4.75M NOK |
| EBITDA | -45849000 NOK |
| Net Income Avi to Common (ttm) | -38039000 NOK |
| Diluted EPS (ttm) | -1.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 51.12M NOK |
| Total Cash Per Share (mrq) | 1.37 NOK |
| Total Debt (mrq) | 671K NOK |
| Total Debt/Equity (mrq) | 1.29 NOK |
| Current Ratio (mrq) | 11.03 |
| Book Value Per Share (mrq) | 1.397 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -42814000 NOK |
| Levered Free Cash Flow (ttm) | -34761624 NOK |
Profile of PCI Biotech Holding ASA
| Country | Norway |
| State | N/A |
| City | Oslo |
| Address | UllernchaussEen 64 |
| ZIP | 0379 |
| Phone | 47 67 11 54 00 |
| Website | https://www.pcibiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.
Q&A For PCI Biotech Holding ASA Stock
What is a current PCIB.OL stock price?
PCI Biotech Holding ASA PCIB.OL stock price today per share is 1.78 NOK.
How to purchase PCI Biotech Holding ASA stock?
You can buy PCIB.OL shares on the Oslo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PCI Biotech Holding ASA?
The stock symbol or ticker of PCI Biotech Holding ASA is PCIB.OL.
Which industry does the PCI Biotech Holding ASA company belong to?
The PCI Biotech Holding ASA industry is Biotechnology.
How many shares does PCI Biotech Holding ASA have in circulation?
The max supply of PCI Biotech Holding ASA shares is 37.33M.
What is PCI Biotech Holding ASA Price to Earnings Ratio (PE Ratio)?
PCI Biotech Holding ASA PE Ratio is now.
What was PCI Biotech Holding ASA earnings per share over the trailing 12 months (TTM)?
PCI Biotech Holding ASA EPS is -0.79 NOK over the trailing 12 months.
Which sector does the PCI Biotech Holding ASA company belong to?
The PCI Biotech Holding ASA sector is Healthcare.
PCI Biotech Holding ASA PCIB.OL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Oslo Bors All-Share Index_GI OSEAX | 1017.37 NOK 97.59 USD |
+1.04
|
371.46M NOK 35.63M USD | 1003.3 NOK 96.24 USD | 1018.4 NOK 97.69 USD | — - | 371.46M NOK 35.63M USD |
- {{ link.label }} {{link}}